Stocks
ResMed (RMD) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | ||||
| EBITDA margin, % | ? | 34.4% | 33.4% | 31.7% | 31.7% | 32.5% | |||
| Changes by years, y/y, % | 0pp | -34pp | -2pp | 0pp | +2.1% | ||||
ResMed. EBITDA margin, %
ResMed. EBITDA margin, changes, pp
ResMed (RMD) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 30.0% | 23.7% | 39.3% | 31.3% | 35.9% | 32.5% | |
| Changes by years, y/y, % | -4pp | -9pp | +6pp | +0pp | +5pp | |||
| Changes by quarters, q/q, % | +0pp | -6pp | +16pp | -8pp | +5pp | |||
